11
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      Are you tired of sifting through news that doesn't interest you?
      Personalize your Karger newsletter today and get only the news that matters to you!

      Sign up

      • Record: found
      • Abstract: found
      • Article: found

      Low Thyroid Hormone Levels Impair the Perinatal Development of the Rat Retina

      research-article

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Eye development is regulated by multiple agents including hormones and growth factors. Thyroid hormone (triiodothyronine, or T<sub>3</sub>, and the prohormone thyroxine, or T<sub>4</sub>) plays a crucial role in the development of the central nervous system. Here we have examined the effects of low T<sub>3</sub>/T<sub>4</sub> levels (hypothyroid status) on the developing rat retina during the perinatal stage. Eyes from control (CG) and T<sub>3</sub>/T<sub>4</sub>-deficient (HG) fetuses (E19 and E21) and newborn (P0, P3, P5 and P7) rats were obtained by administering a chemical antithyroid solution (0.02% methyl-mercaptoimidazole +1% ClOK<sub>4</sub>) in the tap water to the dams and their offspring, from E9 and throughout gestation until they were killed. Perinatal eyes were processed for light and electron transmission microscopy and subjected to morphological and morphometric analyses. Low T<sub>3</sub>/T<sub>4</sub> levels led to decreased retinal growth during the perinatal stage. In addition, the retinas from the HG presented fewer neuroblasts than those of their euthyroid counterparts (at E21: 705 ± 83 cells per constant area of 4 × 10<sup>4</sup> µm<sup>2</sup> vs. 440 ± 60 cells per constant area of 4 × 10<sup>4</sup> µm<sup>2</sup>; p = 0.010). During development the index of mitosis in the retina peaked at E21, falling at the end of the 1st postnatal week. Significantly lower values were observed in the HG (at P5: 0.803 ± 0.374 mitoses/cells % vs. 0.349 ± 0.180 mitoses/cells %; p = 0.004). Furthermore, we have found that low T<sub>3</sub>/T<sub>4</sub> levels delayed and/or altered a series of developmental processes occurring in the retina during the perinatal stage such as layering and differentiation of several cell types. Our results demonstrate that thyroid hormone regulates rat neuroretinogenesis.

          Related collections

          Author and article information

          Journal
          ORE
          Ophthalmic Res
          10.1159/issn.0030-3747
          Ophthalmic Research
          S. Karger AG
          0030-3747
          1423-0259
          2002
          August 2002
          16 September 2002
          : 34
          : 4
          : 181-191
          Affiliations
          aDepartment of Cellular Biology and Pathology, Research Centre University Hospital La Fe, and bResearch Unit of the Department of Ophthalmology, University Hospital Dr. Peset, Valencia, and cInstituto de Investigaciones Biomédicas ‘Alberto Sols’, Consejo Superior de Investigaciones Científicas, Universidad Autónoma de Madrid, Spain
          Article
          63885 Ophthalmic Res 2002;34:181–191
          10.1159/000063885
          12297689
          63588b28-970d-43ed-bb8e-e029cf744525
          © 2002 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          History
          : 07 January 2001
          : 19 March 2002
          Page count
          Figures: 6, Tables: 2, References: 43, Pages: 11
          Categories
          Original Paper

          Vision sciences,Ophthalmology & Optometry,Pathology
          Neuroblasts,Development,Retina,Thyroid hormone,Morphometry

          Comments

          Comment on this article